May 15, 2019, MedPage Today 

Cytologic testing every 3 years for women (ages 21 to 29) with either continued cytologic testing every 3 years or switching to a low-cost high-risk human papillomavirus (hrHPV) test every 5 years (ages 30 to 65), were the two most cost-effective strategies for cervical cancer screening, researchers reported. 

Read more.